Home
Goodwin Procter LLP
James Breen
James Breen
Goodwin Procter LLP
Issue 43: PTAB Trial Tracker
17 Jan 2024 | United States
Goodwin Releases Update To Its Comprehensive Guide To Biosimilars Litigation And Regulation In The U.S.
16 Jan 2024 | United States
BYOOVIZ® (Ranibizumab-Nuna) Granted Interchangeable Status
16 Nov 2023 | United States
Infliximab Clinical Trial Updates
15 Aug 2022 | United States
FDA Testimony Before The U.S. Senate Regarding Reauthorization Of The Biosimilar User Fee Act
02 May 2022 | United States
Contact Details
New York
Email Website
New York
United States

  © Mondaq® Ltd 1994 - 2024. All Rights Reserved.